發(fā)布時(shí)間：2018-03-10 13:30

  本文選題：奶牛乳房炎　切入點(diǎn)：病原　出處：《甘肅農(nóng)業(yè)大學(xué)》2016年博士論文　論文類型：學(xué)位論文

【摘要】：奶牛乳房炎是造成奶牛飼養(yǎng)行業(yè)經(jīng)濟(jì)損失的重要原因之一。經(jīng)過多年的認(rèn)識(shí)和研究,已經(jīng)建立起來了比較完備的預(yù)防和控制體系;但是,在畜牧業(yè)相對(duì)落后的發(fā)展中國家,由于疾病防控理論和實(shí)踐相對(duì)落后,該病造成的經(jīng)濟(jì)損失依然非常嚴(yán)重。減少和杜絕奶牛乳房炎的發(fā)生,對(duì)于提高牛群健康狀態(tài)、保障和提高動(dòng)物福利,對(duì)于提升乳制品的安全性和質(zhì)量都是非常必要的。因此,開發(fā)一種能夠普遍應(yīng)用于奶牛的疫苗就顯得尤為重要,而基因工程重組疫苗,是達(dá)成此目的的最有前景的研究方向之一。由于奶牛乳房炎病因復(fù)雜、病原種類繁多且具有很強(qiáng)的地域分布特性,單一菌株疫苗對(duì)于特定的牛群能夠取得較好的預(yù)防效果,但對(duì)于不同地區(qū)病原種類不同的牛群,不但免疫過程費(fèi)時(shí)費(fèi)力、難以取得滿意的預(yù)防效果,還會(huì)因?yàn)樽⑸湟呙鐣r(shí)的應(yīng)激反應(yīng)而影響牛群的產(chǎn)奶量。簡(jiǎn)單地將多種病原滅活混合,則容易導(dǎo)致免疫劑量過大而炎癥反應(yīng)嚴(yán)重,或是抗原含量不足,免疫效果不夠理想的僵局。而基因工程亞單位疫苗的出現(xiàn),使得這一看似無從下手的難題有了新的希望:針對(duì)病原種類較多的事實(shí),可以考慮重點(diǎn)選擇同一病原的幾個(gè)關(guān)鍵性的保護(hù)性抗原,進(jìn)而將多種病原的保護(hù)性抗原組合在一起,最終以一種多價(jià)、多聯(lián)重組亞單位疫苗的形式出現(xiàn),有望解決免疫劑量過大的難題,也可以解決由于抗原量不足而難以誘導(dǎo)產(chǎn)生有效的保護(hù)力的問題。本研究將傳統(tǒng)的生化鑒定與分子生物學(xué)技術(shù)鑒定相結(jié)合,對(duì)甘肅及周邊地區(qū)采集的乳房炎乳樣進(jìn)行病原菌的分離和鑒定;通過分子生物學(xué)技術(shù),分析分離菌株的毒力基因和抗藥基因的頻率分布;采用微量肉湯稀釋法分析分離菌株對(duì)臨床常用抗生素的敏感情況;應(yīng)用基因工程技術(shù),構(gòu)建分離菌株的真核表達(dá)載體;經(jīng)轉(zhuǎn)染人乳腺癌細(xì)胞表達(dá)及蛋白純化后,對(duì)Balb/c小鼠進(jìn)行免疫和攻毒試驗(yàn),評(píng)價(jià)重組ClfA蛋白疫苗和DNA疫苗對(duì)Balb/c小鼠的免疫保護(hù)效果。對(duì)甘肅及周邊地區(qū)采集的380份乳樣進(jìn)行病原分離鑒定,主要得到金黃色葡萄球菌(Staphylococcus aureus)45株、腸球菌(Enterococcus spp.)60株、大腸桿菌(Escherichia coli)13株、哈弗尼亞細(xì)菌(Hafnia)9株、鏈球菌(Streptococcus spp.)8株。采用微量肉湯稀釋法,分析金黃色葡萄球菌對(duì)10種常用抗生素的耐藥情況;其中,高于80%的金黃色葡萄球菌對(duì)環(huán)丙沙星、慶大霉素、卡那霉素和氯霉素均保持敏感,而對(duì)青霉素、氨芐西林、萬古霉素具有了耐受性,此外,42%的菌株對(duì)對(duì)四環(huán)素具有耐受性。腸球菌對(duì)青霉素普遍耐受,有50%腸球菌和22%的腸球菌能夠耐受高濃度的慶大霉素(500μg/ml)和鏈霉素(1000μg/ml),絕大部分菌株對(duì)氨芐青霉素、萬古霉素和四環(huán)素敏感;分離獲得的大腸桿菌中對(duì)四環(huán)素的耐受程度較高(6/13),對(duì)其余測(cè)試的抗生素基本保持敏感。采用PCR技術(shù)篩選金黃色葡萄球菌毒力基因攜帶情況,其中,金黃色葡萄球菌對(duì)ClfA、FnbA、hlb、hld、hlg、seb檢出率較高,檢出率依次為91%、88%、94%、91%、76%和64%;agr、lukS/E/M、hla、edin、eta、etb、tst和sea/c/d/e/g/i/j/n/o/m均未檢測(cè)到。成功構(gòu)建了金黃色葡萄球菌ClfA-pcDNA 3.1 V5-His B、腸球菌esp-pcDNA3.1 V5-His B、大腸桿菌LPS-pcDNA 3.1 V5-His B和金黃色葡萄球菌hlb-pcDNA3.1 V5-His B 4個(gè)真核表達(dá)載體。重組ClfA表達(dá)載體在MCF-7細(xì)胞中成功表達(dá),經(jīng)western blotting驗(yàn)證具有與天然蛋白產(chǎn)物相似的抗原特性。動(dòng)物免疫保護(hù)試驗(yàn)中,重組ClfA蛋白免疫組小鼠的白細(xì)胞介素、免疫球蛋白和干擾素水平均顯著高于對(duì)照組,表明重組蛋白能夠給受免疫動(dòng)物提供足夠的保護(hù)力,符合良好的疫苗靶標(biāo)特性,具有進(jìn)一步開發(fā)應(yīng)用的潛力。上述研究從實(shí)際出發(fā),為深入研究和開發(fā)奶牛乳房炎病原菌多價(jià)、多聯(lián)基因工程重組亞單位疫苗提供理論和實(shí)踐材料。
[Abstract]:Mastitis is one of the major causes of dairy industry economic losses. After understanding and research for many years, has established a relatively complete system of prevention and control; however, in animal husbandry is relatively backward developing countries, because of the disease prevention and control theory and practice is relatively backward, the disease caused by the economic loss is still very serious. And prevent mastitis in dairy cows, cattle to improve health, protect and improve animal welfare, is necessary for the safety and quality of dairy products. Therefore, the development of a vaccine can be widely used in dairy cows is particularly important, and the recombinant gene engineering vaccine, is one of the research directions for this purpose the most promising because of mastitis etiology is complex, many kinds of pathogens and has a strong geographical characteristics of the distribution, the single strain vaccine for specific Cattle can obtain good preventive effect, but for different regions different pathogenic species of cattle, not only the immune process is time consuming, it is difficult to obtain satisfactory results but also because of prevention, response to stress vaccination and affect milk production of cattle. Simply a variety of pathogenic inactivated mixed, can easily lead to excessive immune dose while severe inflammation, or lack of immune antigen content, the effect is not ideal and deadlock. Genetic engineering subunit vaccine, a new hope to make this seemingly impossible for many pathogenic species can be considered the key facts, choose the same pathogen several key protective antigen, the combination of protective antigens of multiple pathogens together, and ultimately to a multivalent, multiple recombinant subunit vaccine appears in the form of immune dose is expected to solve the problem of the large can In order to solve the stress protective antigen is not sufficient to induce effective problems. The traditional biochemical identification and molecular biology identification technology combined with the acquisition of Gansu and the surrounding areas of the mastitis milk samples for isolation and identification of pathogens; by molecular biological technology, analysis of the frequency distribution of virulence genes of isolates the drug resistance gene; analysis of sensitivity of isolates to antibiotics by using broth microdilution method; gene engineering technique was used to construct the eukaryotic expression vector were isolated by expression of breast cancer cells; transfection and protein purification, immunity and infection test of Balb/c mice to evaluate the effect of immune protection Balb/c mouse ClfA recombinant protein vaccine and DNA vaccine. The pathogen isolation and identification of the acquisition of Gansu and the surrounding areas of the 380 milk samples, mainly by the golden yellow grape ball Bacteria (Staphylococcus aureus) and 45 strains of Enterococcus (Enterococcus spp.) and 60 strains of Escherichia coli (Escherichia coli) 13 strains of bacteria (Hafnia), Harvard, 9 strains, 8 strains of Streptococcus (Streptococcus spp.). By using the broth microdilution method, analysis of 10 kinds of antibiotic resistant Staphylococcus aureus; among them, more than 80% of the Staphylococcus aureus to ciprofloxacin, gentamicin, kanamycin and chloramphenicol were sensitive to penicillin, ampicillin, vancomycin and, with tolerance, in addition, 42% strains was tolerant to penicillin of Enterococcus to the city of Victoria. Generally well tolerated, 50% and 22% to the Enterococcus Enterococcus in high concentration tolerance to gentamicin (500 g/ml) and streptomycin (1000 g/ml), most of the strains sensitive to ampicillin, vancomycin and tetracycline; isolated Escherichia coli with tolerance to tetracycline High (6/13), for the rest of the antibiotics tested remained sensitive. Screening of Staphylococcus aureus virulence genes, which adopts PCR technology, Staphylococcus aureus ClfA, FnbA, HLB, HLD, HLG, SEB detection rate is higher, the incidence rate was 91%, 88%, 94%, 91%, 76% and 64% agr; lukS/E/M, HLA, Edin, ETA, ETB, TST, and sea/c/d/e/g/i/j/n/o/m were not detected. The successful construction of Staphylococcus aureus ClfA-pcDNA 3.1 V5-His B esp-pcDNA3.1 V5-His B, Enterococcus, Escherichia coli LPS-pcDNA 3.1 V5-His B and Staphylococcus aureus hlb-pcDNA3.1 V5-His B 4 eukaryotic expression vector. The recombinant expression vector in ClfA MCF-7 cells successfully expressed antigen characteristics similar to natural protein with Western blotting. Verify the animal immune protection test, interleukin ClfA recombinant protein immunized mice, immune globulin and interferon levels were significantly Than that of control group, showed that the recombinant protein to the immune animal protection provides enough, in line with the characteristics of a good vaccine targets, with the further development and application potential. The research from the actual situation, for further research and development of dairy cow mastitis pathogen multivalent, multiple genetic engineering subunit vaccine to provide theoretical and practical material.

【學(xué)位授予單位】：甘肅農(nóng)業(yè)大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2016
【分類號(hào)】：S852.61

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 郭鳳芹,劉秀麗,武朝霞;奶牛乳房炎的防治[J];張家口農(nóng)專學(xué)報(bào);2003年04期

2 孔雪旺;陳功義;;奶牛乳房炎病原菌的分離鑒定及藥敏試驗(yàn)[J];中國奶牛;2007年01期

3 代敏;王雄清;王紅寧;羅英;陳希文;郭文宇;;綿陽市奶牛乳房炎病原菌的分離鑒定及耐藥性分析[J];中國獸醫(yī)雜志;2007年03期

4 夏勝超;吳聰明;王紹琛;劉金鳳;沈建忠;;奶牛乳房炎病例中金黃色葡萄球菌毒素基因的檢測(cè)[J];中國獸醫(yī)雜志;2007年04期

5 郎景民;布日額;張婷;劉麗;姬守德;;奶牛乳房炎生物制劑研究進(jìn)展[J];內(nèi)蒙古民族大學(xué)學(xué)報(bào)(自然科學(xué)版);2009年05期

6 伍清林，，金蘭梅，汲軍;奶牛乳房炎與氣候關(guān)系的探討[J];中國農(nóng)業(yè)氣象;1994年06期

7 蘇志強(qiáng);;中草藥防治奶牛乳房炎[J];青年科學(xué);2007年08期

8 劉忠琛;李加香;;如何防治奶牛乳房炎[J];科技致富向?qū)?2000年09期

9 冀玉湞,閆常平,孫文毅,黃俊武,許臘梅;奶牛乳房炎病原菌的分離與鑒定[J];畜牧獸醫(yī)科技信息;2005年01期

10 劉文進(jìn),陳創(chuàng)夫,滕文軍,吳潔,任雪艷;新疆墾區(qū)奶牛乳房炎致病菌的調(diào)查[J];中國草食動(dòng)物;2005年02期

相關(guān)會(huì)議論文 前10條

1 李宏勝;郁杰;羅金印;李新圃;徐繼英;嚴(yán)作廷;李世宏;陳化奇;;奶牛乳房炎研究進(jìn)展[A];中國畜牧獸醫(yī)學(xué)會(huì)家畜內(nèi)科學(xué)分會(huì)2009年學(xué)術(shù)研討會(huì)論文集[C];2009年

2 崔群維;王根林;;奶牛乳房炎分子水平診斷的研究進(jìn)展[A];中國牛業(yè)健康發(fā)展與科技創(chuàng)新——中國畜牧獸醫(yī)學(xué)會(huì)第七屆養(yǎng)牛學(xué)分會(huì)2009年學(xué)術(shù)研討會(huì)論文集[C];2009年

3 孫英峰;丁伯良;;奶牛乳房炎的血液學(xué)變化[A];中國畜牧獸醫(yī)學(xué)會(huì)獸醫(yī)病理學(xué)分會(huì)第十六次學(xué)術(shù)研討會(huì)、中國病理生理學(xué)會(huì)動(dòng)物病理生理專業(yè)委員會(huì)第十五次學(xué)術(shù)研討會(huì)論文集[C];2009年

4 陳建國;趙雅心;劉東明;胡長(zhǎng)敏;丁明星;;腫瘤壞死因子α及其受體在奶牛乳房炎抗感染作用的研究[A];中國畜牧獸醫(yī)學(xué)會(huì)獸醫(yī)產(chǎn)科學(xué)分會(huì)第五屆全體會(huì)議第十次學(xué)術(shù)研討會(huì)論文集[C];2009年

5 劉修權(quán);高健;韓博;;奶牛乳房炎檢測(cè)技術(shù)研究進(jìn)展[A];中國畜牧獸醫(yī)學(xué)會(huì)2010年學(xué)術(shù)年會(huì)——第二屆中國獸醫(yī)臨床大會(huì)論文集(上冊(cè))[C];2010年

6 張久榮;;防治夏季奶牛乳房炎的新方法[A];“科技進(jìn)步推進(jìn)畜牧業(yè)現(xiàn)代化”科技論文集[C];2011年

7 馬

本文編號(hào)：1593550